Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00312182 · ClinicalTrials.gov registry record · Phase 4
Thorough QT Study of Nelfinavir
A Phase 4 study of Healthy Volunteers, sponsored by Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 68
- Enrollment target
- 4
- Study locations
NCT00312182 is a Phase 4 study of Healthy Volunteers that has completed, run by Pfizer. The registered enrollment target is 68 participants, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (86% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT00312182, a Phase 4 study of Healthy Volunteers, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 68 participants
- Enrollment target
- 4
- Study locations
Study Summary
To assess if nelfinavir has any clinically meaninful effect on cardiac function, namely ECG evaluation
Conditions Studied
Interventions
- DRUG Nelfinavir
Study Locations (4)
Other
- Pfizer Investigational Site - Brussels
- Pfizer Investigational Site - Singapore
Connecticut
- Pfizer Investigational Site - New Haven
Michigan
- Pfizer Investigational Site - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2006-03 |
| Est. Completion | 2006-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00312182
The ClinicalTrials.gov registry entry for NCT00312182 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (86% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 1 intervention - of which Nelfinavir is the first listed.
NCT00312182 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Other, Connecticut, Michigan.
Frequently Asked Questions
What is clinical trial NCT00312182 about?
NCT00312182 is a clinical study titled "Thorough QT Study of Nelfinavir". To assess if nelfinavir has any clinically meaninful effect on cardiac function, namely ECG evaluation
What is the current status of trial NCT00312182?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 68 participants. The study started on 2006-03. Estimated completion is 2006-06.
What conditions does trial NCT00312182 study?
This clinical trial studies the following conditions: Healthy Volunteers.
What interventions are being tested in trial NCT00312182?
The interventions under investigation include: Nelfinavir (DRUG).
Who is sponsoring clinical trial NCT00312182?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00312182 being conducted?
This trial has 4 study locations across Connecticut, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Energy Drinks on Cardiovascular Endpoints
RECRUITING · Phase 4
-
KarXT Concentrations in the Breast Milk and Plasma of Lactating Females
RECRUITING · Phase 4
-
Investigation of the Gut Microbiome and Statin Response
ACTIVE NOT RECRUITING · Phase 4
-
A Study to Investigate Cardiac Troponin Levels After mRNA-1273.712 Vaccine in Participants 12 Through 30 Years of Age
COMPLETED · Phase 4
-
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
COMPLETED · Phase 4
-
Adaptive Optics Retinal Imaging
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.